---
title: "CLGN Q1'26 Earnings: revenue estimate is 460.00K USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286403568.md"
description: "CollPlant Biotechnologies Ltd. (CLGN) will announce its Q1'26 earnings on May 21 at 8:00 AM ET. The revenue estimate is $460,000, with an anticipated EPS of -$0.24. Previous quarters showed significant revenue surprises and varying EPS results. For Q1'25, reported revenue was $2.06 million, with estimates for Q1'26 significantly lower. The data is sourced from FactSet."
datetime: "2026-05-14T11:00:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286403568.md)
  - [en](https://longbridge.com/en/news/286403568.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286403568.md)
---

# CLGN Q1'26 Earnings: revenue estimate is 460.00K USD

CLGN (CollPlant Biotechnologies Ltd.) is set to announce its Q1'26 results on May 21, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 460.00 thousand USD with EPS (earnings per share) anticipated at (0.24) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

2.06 M

179.00 K

77.00 K

—

—

**Revenue Estimate**

2.65 M

2.54 M

4.84 M

2.08 M

460.00 K

**Revenue Surprise**

\-22.31%

\-92.96%

\-98.41%

**EPS Reported**

(0.13)

(0.28)

(0.27)

**EPS Estimate**

(0.04)

(0.10)

0.16

(0.30)

(0.24)

**EPS Surprise**

\-225.00%

\-180.00%

\-273.80%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [CLGN.US](https://longbridge.com/en/quote/CLGN.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)